Monte Rosa Therapeutics

GLUE

Börsenwert 909 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
151	151 Ameritas Investment Partners Lincoln, Nebraska	162.624 $	+33.406 $	+1.768	+36 %
152	152 Tower Research Capital (TRC) New York	148.588 $	+45.688 $	+2.418	+65 %
153	153 Rockefeller Capital Management New York	128.139 $	–	–	–
154	154 Nisa Investment Advisors St. Louis, Missouri	118.846 $	+3.023 $	+160	+3 %
155	155 Vestcor Inc Fredericton, New Brunswick, Canada	102.000 $	–	–	–
156	156 Mirae Asset Global Investments Seoul, South Korea	91.428 $	-3.760 $	-199	-5 %
157	C 157 Covestor London, United Kingdom	79.000 $	+61.654 $	+3.263	+65.260 %
158	158 EverSource Wealth Advisors Birmingham, Alabama	76.303 $	-8.937 $	-473	-13 %
159	159 Royal Bank of Canada Toronto, Ontario, Canada	76.000 $	+18.819 $	+996	+46 %
160	160 STRS Ohio Columbus, Ohio	70.180 $	-752.013 $	-39.800	-93 %
161	161 Osaic Holdings Scottsdale, Arizona	64.153 $	+19.972 $	+1.057	+66 %
162	162 GAMMA Investing Foster City, California	51.159 $	+1.625 $	+86	+4 %
163	163 GF Fund Management Guangzhou, China	39.107 $	+3.080 $	+163	+11 %
164	164 Allworth Financial Folsom, California	29.912 $	-1.323 $	-70	-5 %
165	165 IFP Advisors Tampa, Florida	28.508 $	-321 $	-17	-1 %
166	PP 166 Paladin Partners Hartland, Wisconsin	24.200 $	–	–	–
167	167 Pacer Advisors Malvern, Pennsylvania	24.000 $	+18.536 $	+981	Neu
168	EP 168 Essential Partners Rancho Santa Fe, California	19.868 $	-230.649 $	-12.207	-94 %
169	KAS 169 Kemnay Advisory Services New York	17.303 $	+13.510 $	+715	Neu
170	170 BNP Paribas Asset Management Paris, France	15.415 $	-16.816 $	-890	-58 %
171	171 Fifth Third Bancorp Cincinnati, Ohio	14.423 $	–	–	–
172	172 PNC Financial Services Group Pittsburgh, Pennsylvania	11.059 $	–	–	–
173	173 Farther Finance Advisors San Francisco, California	7.614 $	+321 $	+17	+6 %
174	WA 174 Westfuller Advisors New York	7.284 $	–	–	–
175	FFO 175 Fortitude Family Office Scottsdale, Arizona	6.365 $	+4.384 $	+232	+748 %

Monte Rosa Therapeutics GLUE Börsenwert 909 Mio. $

Monte Rosa Therapeutics

GLUE

Börsenwert 909 Mio. $